Sildenafil Citrate

CAS 171599-83-0 21 current records 2 historicalSmall Molecule

Who holds supplier records for Sildenafil Citrate? 21 organisations hold a current record for Sildenafil Citrate: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 18 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (15), China (2) and Poland (1); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Sildenafil Citrate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sildenafil-citrate

Reading the evidence

  • 21 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    15 of the 18 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (21)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Sildenafil Citrate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India15China2Poland1Country not recorded for 3
Need Sildenafil Citrate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (18)

Certificates of Suitability on the EDQM register for Sildenafil Citrate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 24 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
HALEOS LABS LIMITED HyderabadIN
CEP 2022-249 - Rev 02
Sildenafil citrate
Jul 2026—
MSN ORGANICS PRIVATE LIMITED Bibinagar VillageIN
CEP 2013-219 - Rev 02
Sildenafil citrate, Micronised and non-micronised
Mar 2026—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2012-317 - Rev 03
Sildenafil citrate
Oct 2025—
RAKSHIT PHARMACEUTICALS LIMITED Anakapalli DistrictIN
CEP 2014-361 - Rev 02
Sildenafil citrate
Sept 2025—
SMILAX LABORATORIES LIMITED HyderabadIN
CEP 2024-155 - Rev 00
Sildenafil citrate
Jul 2025—
SMS PHARMACEUTICALS LIMITED HyderabadIN
CEP 2025-066 - Rev 00
Sildenafil citrate, Unit-VII
Apr 2025—
AMOLI ORGANICS PRIVATE LIMITED MumbaiIN
CEP 2014-223 - Rev 02
Sildenafil citrate
Mar 2025—
HETERO DRUGS LIMITED HyderabadIN
CEP 2013-002 - Rev 01
Sildenafil citrate
Jan 2025—
ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard GdańskiPL
CEP 2013-073 - Rev 04
Sildenafil citrate, Process B, standard, milled and micronised
Nov 2024Inspected Jul 2026
Poland
TORRENT PHARMACEUTICALS LIMITED AhmedabadIN
CEP 2013-346 - Rev 02
Sildenafil citrate
Oct 2024—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2014-050 - Rev 02
Sildenafil citrate
Jul 2024—
ANDHRA ORGANICS LIMITED Pydibhimavaram VillageIN
CEP 2022-251 - Rev 00
Sildenafil citrate
Mar 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2012-375 - Rev 01
Sildenafil citrate
Jan 2024—
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Taizhou CityCN
CEP 2013-332 - Rev 04
Sildenafil citrate
Sept 2023Inspected Nov 2025
Hungary
AZICO BIOPHORE INDIA PRIVATE LIMITED HyderabadIN
R1-CEP 2016-336 - Rev 00
Sildenafil citrate
May 2023—
PHARMACEUTICAL WORKS POLPHARMA S.A. Starogard GdanskiPL
R1-CEP 2013-072 - Rev 02
Sildenafil citrate, Process A
Mar 2022—
RAKS PHARMA PVT. LTD. VisakhapatnamIN
R1-CEP 2014-246 - Rev 00
Sildenafil citrate
Jan 2021—
CADILA PHARMACEUTICALS LIMITED AnkleshwarIN
R1-CEP 2013-291 - Rev 00
Sildenafil citrate
Dec 2019—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Sildenafil Citrate are no longer active. These show a past filing, not current supply.

Show all 2 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Sildenafil Citrate is a phosphodiesterase type 5 (PDE5) inhibitor used primarily to treat erectile dysfunction and pulmonary arterial hypertension. It facilitates vasodilation and increased blood flow in the corpus cavernosum by selective inhibition of PDE5.

Chemical identity

IUPAC name
5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,5-d]pyrimidin-7-one;2-hydroxypropane-1,2,3-tricarboxylic acid
Canonical SMILES
CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChIKey
DEIYFTQMQPDXOT-UHFFFAOYSA-N
Synonyms
Revatio API, liqrev, nsc-744009, nsc-758669, revatio, sildenafil (as citrate), uk-92,480-10, uk-92480-10, viagra, vrbrique, vybrique

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Phosphodiesterase 5 Inhibitor
Mechanism of action
Phosphodiesterase 5 Inhibitors

Therapeutic areas

CardiovascularUrogenital

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Sildenafil Citrate?

21 organisations hold an active US FDA Type II Drug Master File or a CEP for Sildenafil Citrate: AMOLI ORGANICS PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), AZICO BIOPHORE INDIA PVT LTD (India), Cadila Pharmaceuticals Limited (India), HALEOS LABS LTD (India), Hetero Drugs Limited (India), Macleods Pharmaceuticals Ltd. (India) and MATRIX PHARMACORP PRIVATE LTD (India), and 13 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Sildenafil Citrate Drug Master Files are active?

AMOLI ORGANICS PRIVATE LTD (DMF 25311), APITORIA PHARMA PRIVATE LTD (DMF 25424), AZICO BIOPHORE INDIA PVT LTD (DMF 29831), Cadila Pharmaceuticals Limited (DMF 21154), HALEOS LABS LTD (DMF 35914), Hetero Drugs Limited (DMF 21619), Macleods Pharmaceuticals Ltd. (DMF 23705) and MATRIX PHARMACORP PRIVATE LTD (DMF 19097) and 9 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Sildenafil Citrate records mean?

2 organisations have only inactive Type II DMFs for Sildenafil Citrate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Sildenafil Citrate have a European Certificate of Suitability?

Yes. 18 organisations hold a valid CEP for Sildenafil Citrate on the EDQM register, including HALEOS LABS LIMITED Hyderabad (IN), MSN ORGANICS PRIVATE LIMITED Bibinagar Village (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), RAKSHIT PHARMACEUTICALS LIMITED Anakapalli District (IN), SMILAX LABORATORIES LIMITED Hyderabad (IN) and SMS PHARMACEUTICALS LIMITED Hyderabad (IN) and 12 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Sildenafil Citrate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Sildenafil Citrate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.